Andrew Callos
Corporate Officer/Principal at CYTOKINETICS, INCORPORATED
Net worth: 4 M $ as of 30/04/2024
Profile
Mr. Andrew Callos is a Chief Commercial Officer & Executive VP at Cytokinetics, Inc. Mr. Callos was previously employed as a Vice President-US Cardiology & Metabolic Marketing by Pfizer Inc. and an Assistant Vice President-Marketing by Wyeth Pharmaceuticals, Inc. He received his undergraduate degree from Drexel University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/03/2024 | 63,887 ( 0.06% ) | 4 M $ | 30/04/2024 |
Andrew Callos active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01/03/2021 |
Former positions of Andrew Callos
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Sales & Marketing | - |
Training of Andrew Callos
| Drexel University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
- Stock Market
- Insiders
- Andrew Callos
